Cargando…

TP53 signature diagnostic system using multiplex reverse transcription–polymerase chain reaction system enables prediction of prognosis of breast cancer patients

BACKGROUND: TP53 status based on TP53 signature, a gene expression profile to determine the presence or absence of TP53 mutation, is an independent prognostic factor of breast cancer. The purpose of this study was to develop a simple diagnostic system for TP53 signature status. METHODS: We developed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takahashi, Shin, Fukui, Takafumi, Nomizu, Tadashi, Kakugawa, Yoichiro, Fujishima, Fumisyoshi, Ishida, Takanori, Ohuchi, Noriaki, Ishioka, Chikashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514380/ https://www.ncbi.nlm.nih.gov/pubmed/34302605 http://dx.doi.org/10.1007/s12282-021-01250-z

Ejemplares similares

Molecular and clinical features of the TP53 signature gene expression profile in early-stage breast cancer
por: Yamaguchi, Shigeo, et al.
Publicado: (2018)

The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
por: Leroy, Bernard, et al.
Publicado: (2013)

Smoking and survival after breast cancer diagnosis in Japanese women: A prospective cohort study
por: Kakugawa, Yoichiro, et al.
Publicado: (2015)

TP53 Signature Can Predict Pathological Response From Neoadjuvant Chemotherapy and Is a Prognostic Factor in Patients With Residual Disease
por: Takahashi, Shin, et al.
Publicado: (2023)

Different impacts of TP53 mutations on cell cycle-related gene expression among cancer types
por: Sasaki, Keiju, et al.
Publicado: (2023)

Increased centrosome number in BRCA‐related breast cancer specimens determined by immunofluorescence analysis
por: Watanabe, Gou, et al.
Publicado: (2018)

Body mass index and survival after breast cancer diagnosis in Japanese women
por: Kawai, Masaaki, et al.
Publicado: (2012)

High throughput RNAi screening identifies ID1 as a synthetic sick/lethal gene interacting with the common TP53 mutation R175H
por: IMAI, HIROO, et al.
Publicado: (2014)

Phase II study of capecitabine and trastuzumab combination chemotherapy in patients with HER2 overexpressing metastatic breast cancers resistant to both anthracyclines and taxanes
por: Ishida, Takanori, et al.
Publicado: (2008)

Cigarette smoking and breast cancer risk in relation to joint estrogen and progesterone receptor status: a case-control study in Japan
por: Nishino, Yoshikazu, et al.
Publicado: (2014)

Multiplex enhancer-reporter assays uncover unsophisticated TP53 enhancer logic
por: Verfaillie, Annelien, et al.
Publicado: (2016)

Accessing a New Dimension in TP53 Biology: Multiplex Long Amplicon Digital PCR to Specifically Detect and Quantitate Individual TP53 Transcripts
por: Lasham, Annette, et al.
Publicado: (2020)

Mitigating the Risk of t-MNs Development: TP53 or Not TP53?
por: Tesio, Melania
Publicado: (2023)

Pneumonia Due to Human Coronavirus OC43 in an Immunocompetent Adult Detected by Multiplex Polymerase Chain Reaction
por: Kawataki, Masanori, et al.
Publicado: (2021)

TP53 and TP53-associated genes are correlated with the prognosis of paediatric neuroblastoma
por: Wang, Haiwei, et al.
Publicado: (2022)

Multiplexed lighting system using time-division multiplexing
por: Ban, Yuki, et al.
Publicado: (2022)

Optimisation of TP53 reporters by systematic dissection of synthetic TP53 response elements
por: Trauernicht, Max, et al.
Publicado: (2023)

RARE-32. PEDIATRIC METASTATIC SKULL BASE CHORDOMA WITH TP53 MUTATION – A CASE REPORT AND REVIEW OF THE LITERATURE
por: Shimada, Akira, et al.
Publicado: (2020)

The TP53 fertility network
por: Paskulin, Diego d’Avila, et al.
Publicado: (2012)

TP53: an oncogene in disguise
por: Soussi, T, et al.
Publicado: (2015)

TP53 in Myelodysplastic Syndromes
por: Jiang, Yan, et al.
Publicado: (2021)

Overexpression of DRAM enhances p53-dependent apoptosis
por: Takahashi, Masahiro, et al.
Publicado: (2013)

Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients
por: Langerød, A, et al.
Publicado: (2000)

Expression signature based on TP53 target genes doesn't predict response to TP53-MDM2 inhibitor in wild type TP53 tumors
por: Sonkin, Dmitriy
Publicado: (2015)

Expression of TP53 Isoforms p53β or p53γ Enhances Chemosensitivity in TP53(null) Cell Lines
por: Silden, Elisabeth, et al.
Publicado: (2013)

IDH2 and TP53 mutations are correlated with gliomagenesis in a patient with Maffucci syndrome
por: Moriya, Kunihiko, et al.
Publicado: (2014)

Evaluation of a newly developed piezo actuator-driven pulsed water jet system for liver resection in a surviving swine animal model
por: Nakanishi, Chikashi, et al.
Publicado: (2016)

Redox-sensitive TP53INP1 SUMOylation as an oxidative stress sensor to activate TP53
por: Bonacci, Thomas, et al.
Publicado: (2014)

TP53 Combined Phenotype Score Is Associated with the Clinical Outcome of TP53-Mutated Myelodysplastic Syndromes
por: Yabe, Mariko, et al.
Publicado: (2021)

TP53_PROF: a machine learning model to predict impact of missense mutations in TP53
por: Ben-Cohen, Gil, et al.
Publicado: (2022)

Induction of p53‐independent Apoptosis Associated with G2M Arrest Following DNA Damage in Human Colon Cancer Cell Lines
por: Arita, Daisaku, et al.
Publicado: (1997)

Updates from the TP53 universe
por: Pentimalli, Francesca
Publicado: (2018)

TP53 in Biology and Treatment of Osteosarcoma
por: Synoradzki, Kamil Jozef, et al.
Publicado: (2021)

The Role of TP53 in Adaptation and Evolution
por: Voskarides, Konstantinos, et al.
Publicado: (2023)

Prognostic value genotypes and LOH at TP53 codon 72 and TP53 mutations in primary breast cancer
por: Kyndi, M, et al.
Publicado: (2005)

The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes
por: McGraw, K L, et al.
Publicado: (2015)

Comprehensive Identification of Deleterious TP53 Missense VUS Variants Based on Their Impact on TP53 Structural Stability
por: Tam, Benjamin, et al.
Publicado: (2021)

TP53 inhibitor PFTα increases the sensitivity of arsenic trioxide in TP53 wildtype tumor cells
por: Wang, Haiwei, et al.
Publicado: (2022)

Alcohol consumption and survival after breast cancer diagnosis in Japanese women: A prospective patient cohort study
por: Minami, Yuko, et al.
Publicado: (2019)

p53/TP53 Status Assessment in Gastroesophageal Adenocarcinoma
por: Boldrin, Elisa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7bosdg9t9t0ndbm9u92tnmm1ip